SuperworthInnospec EPS IOSP
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $4.90
- Latest quarter, Q2 FY26
- $1.25
- +33% on a year earlier
- Fiscal year 2025
- $4.68
- +234% on the year before
Innospec's earnings per share was $4.90 over the twelve months to Jun 30, 2026, up 545% on a year earlier.
In its latest quarter, Q2 FY26, it was $1.25, up 33% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 33% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $4.68 | +234% |
| FY2024 | $1.40 | −75% |
| FY2023 | $5.57 | +5% |
| FY2022 | $5.32 | +42% |
| FY2021 | $3.74 | +228% |
| FY2020 | $1.14 | −75% |
| FY2019 | $4.54 | +31% |
| FY2018 | $3.46 | +38% |
| FY2017 | $2.51 | −25% |
| FY2016 | $3.33 | −31% |
| FY2015 | $4.86 | +43% |
| FY2014 | $3.39 | +5% |
| FY2013 | $3.22 | +13% |
| FY2012 | $2.86 | +44% |
| FY2011 | $1.98 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.25 | +33% | $4.90 | |
| Q1 FY26 | $1.22 | −7% | $4.59 | |
| Q4 FY25 | $1.91 | n/a | $4.68 | |
| Q3 FY25 | $0.52 | −61% | −$0.05 | |
| Q2 FY25 | $0.94 | −24% | $0.76 | |
| Q1 FY25 | $1.31 | −21% | $1.06 | |
| Q4 FY24 | −$2.82 | −287% | $1.40 | |
| Q3 FY24 | $1.33 | −15% | $5.73 | |
| Q2 FY24 | $1.24 | +7% | $5.97 | |
| Q1 FY24 | $1.65 | +24% | $5.89 | |
| Q4 FY23 | $1.51 | +48% | $5.57 | |
| Q3 FY23 | $1.57 | +1% | $5.08 |
Against its peers
Companies in Chemicals nearest Innospec's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| IOSPInnospec | $4.90 | +545% a year |
| NGVTIngevity | $1.47 | |
| ROGRogers | $1.75 | |
| FULFuller H B | $3.59 | +72% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| AVNTAvient | $1.85 | +43% a year |
| CBTCabot | $3.54 | −54% a year |
| CRONCronos | $0.20 | +300% a year |
| CSWCSW Industrials | $7.29 | −13% a year |
| BCPCBalchem | $5.09 | +16% a year |
| HXLHexcel | $1.99 | +84% a year |
| Peer median | $2.77 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Innospec
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.